Here at Botanix, we are at the forefront of dermatological innovation. With a world-class team and significant capital, we are committed to addressing common yet underserved skin diseases and infections.

As an ASX-listed company, we are in a prime position to develop and commercialise groundbreaking treatments across broad markets, all while adhering to the highest clinical standards set by the US FDA.